Cnvi.V
CNVI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and solutions to healthcare providers and patients.
Business. CNVI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and solutions to healthcare providers and patients.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CNVI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical devices and solutions to healthcare providers and patients.
The company's capital structure is highly leveraged, with total liabilities of CAD 30.5 million and total equity of CAD -18.0 million, resulting in a debt-to-equity ratio of -1.1. Despite holding CAD 5.8 million in cash and equivalents, the company's liquidity is constrained by its CAD 19.9 million in long-term debt, and its operating cash flow of CAD -25.1 million indicates significant cash outflows from operations. The current ratio of 1.01 suggests the company is barely able to cover its short-term obligations with its current assets.
Profitability is a major concern, as the company reported a net loss of CAD 20.5 million and an operating loss of CAD 19.8 million in the latest period. Return on equity (ROE) is positive at 1.14%, but this is misleading due to the negative equity base, and return on assets (ROA) is negative at -1.65%, indicating poor asset utilization. The company's gross profit of CAD 7.6 million is insufficient to cover operating expenses, highlighting inefficiencies in cost management.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic or regulatory risks, though specific geographic breakdowns are not available in the current dataset.
Growth appears to be under pressure, with no clear revenue growth trajectory provided in the data. The company's free cash flow of CAD -19.9 million and capital expenditures of CAD -183,000 suggest limited reinvestment capacity and ongoing operational challenges. Analysts have assigned a mean price target of CAD 1.00, but the absence of strong buy ratings and the presence of only one buy recommendation indicate cautious sentiment.
The company faces significant liquidity and solvency risks, with a negative net cash position after subtracting total debt. The risk of dilution is currently low, but the company's negative equity and high debt levels could necessitate equity financing in the future, potentially leading to share dilution. No recent events or filings are disclosed in the provided data to suggest immediate changes in the company's risk profile.
The company's recent financial performance and risk profile suggest a challenging outlook. The absence of strong buy ratings and the negative operating cash flow indicate that the company may struggle to attract investor confidence without significant operational improvements or restructuring.
- CNVI.V is operating at a significant net loss, with a negative return on assets and a high debt-to-equity ratio.
- The company's liquidity is constrained by its negative net cash position and high debt levels.
- Analysts have assigned a mean price target of CAD 1.00, but the absence of strong buy ratings suggests cautious sentiment.
- The company's revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
- The company's free cash flow is negative, and capital expenditures are minimal, indicating limited reinvestment capacity.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- CNVI.V Market data — financials · 2026-05-27
- Conavi Medical Corp Market data — analyst estimates · 2026-05-27